1. Candesartan is associated with lower amyloid accumulation in non‐hypertensive prodromal Alzheimer's disease. (31st December 2021) Authors: Okafor, Maureen; Wan, Limeng; Saleh, Sabria; Moore, Renee' H; Shaw, Les M; Goldstein, Felicia C; Hajjar, Ihab Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Candesartan is associated with lower amyloid accumulation in non‐hypertensive prodromal Alzheimer's disease. (31st December 2021) Authors: Okafor, Maureen; Wan, Limeng; Saleh, Sabria; Moore, Renee' H; Shaw, Les M; Goldstein, Felicia C; Hajjar, Ihab Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P2‐451: RECOGNITION MEMORY PERFORMANCE AS A COGNITIVE MARKER OF PRODROMAL ALZHEIMER'S DISEASE. (1st July 2019) Authors: Goldstein, Felicia C.; Loring, David W.; Thomas, Tiffany; Saleh, Sabria; Hajjar, Ihab Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 15 Page Start: P787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. UTILITY OF EXECUTIVE FUNCTION TO IDENTIFY EARLY COGNITIVE IMPAIRMENT IN AFRICAN AMERICANS. (8th November 2019) Authors: Garrett, Stephanie; Goldstein, Felicia C; Chen, Yunyun; Easley, Kirk; McDaniel, Darius; Lea, Janice; Thomas, Tiffany; Saleh, Sabria; Hajjar, Ihab Journal: Innovation in aging Issue: Volume 3(2019)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗